共 50 条
- [2] Real-world use of nirmatrelvir-ritonavir: who benefits? LANCET INFECTIOUS DISEASES, 2023, 23 (07): : 765 - 767
- [6] Nirmatrelvir-ritonavir (Paxlovid®), a treatment for Covid-19 ACTUALITES PHARMACEUTIQUES, 2020, 61 (617): : 10 - 12
- [9] Nirmatrelvir-Ritonavir and Viral Load Rebound in Covid-19 NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (11): : 1047 - 1049